163 related articles for article (PubMed ID: 2196342)
1. Cerebrotendinous xanthomatosis: clinical, electrophysiological and nerve biopsy findings, and response to treatment with chenodeoxycholic acid.
Donaghy M; King RH; McKeran RO; Schwartz MS; Thomas PK
J Neurol; 1990 Jun; 237(3):216-9. PubMed ID: 2196342
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
Pedley TA; Emerson RG; Warner CL; Rowland LP; Salen G
Ann Neurol; 1985 Oct; 18(4):517-8. PubMed ID: 4073846
[TBL] [Abstract][Full Text] [Related]
3. Sensory action potentials and biopsy of the sural nerve in neuropathy.
Behse F; Buchthal
Brain; 1978 Sep; 101(3):473-93. PubMed ID: 213163
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.
Kuriyama M; Tokimura Y; Fujiyama J; Utatsu Y; Osame M
J Neurol Sci; 1994 Aug; 125(1):22-8. PubMed ID: 7964884
[TBL] [Abstract][Full Text] [Related]
5. Cerebrotendinous xanthomatosis: treatments with simvastatin, lovastatin, and chenodeoxycholic acid in 3 siblings.
Peynet J; Laurent A; De Liege P; Lecoz P; Gambert P; Legrand A; Mikol J; Warnet A
Neurology; 1991 Mar; 41(3):434-6. PubMed ID: 2006015
[TBL] [Abstract][Full Text] [Related]
6. De- and remyelination and onion bulb in cerebrotendinous xanthomatosis.
Ohnishi A; Yamashita Y; Goto I; Kuroiwa Y; Murakami S; Ikeda M
Acta Neuropathol; 1979 Jan; 45(1):43-5. PubMed ID: 760364
[TBL] [Abstract][Full Text] [Related]
7. The neuropathy of Charlevoix-Saguenay ataxia: an electrophysiological and pathological study.
Peyronnard JM; Charron L; Barbeau A
Can J Neurol Sci; 1979 May; 6(2):199-203. PubMed ID: 487311
[TBL] [Abstract][Full Text] [Related]
8. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.
Moghadasian MH; Salen G; Frohlich JJ; Scudamore CH
Arch Neurol; 2002 Apr; 59(4):527-9. PubMed ID: 11939886
[TBL] [Abstract][Full Text] [Related]
9. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid in three siblings.
Chang WN; Kuriyama M; Chee EC
J Formos Med Assoc; 1994 Mar; 93(3):256-9. PubMed ID: 7920069
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis.
Nakamura T; Matsuzawa Y; Takemura K; Kubo M; Miki H; Tarui S
Metabolism; 1991 Jul; 40(7):741-6. PubMed ID: 1908036
[TBL] [Abstract][Full Text] [Related]
11. Peripheral neuropathy in cerebrotendinous xanthomatosis.
Katz DA; Scheinberg L; Horoupian DS; Salen G
Arch Neurol; 1985 Oct; 42(10):1008-10. PubMed ID: 2994606
[TBL] [Abstract][Full Text] [Related]
12. [A case of cerebrotendinous xanthomatosis with spastic paraparesis, epilepsy, and bradykinesia].
Kondo R; Wakamatsu N; Ishikawa A; Yuasa T; Miyatake T
Rinsho Shinkeigaku; 1991 Jun; 31(6):677-9. PubMed ID: 1934787
[TBL] [Abstract][Full Text] [Related]
13. Evoked potentials in cerebrotendinous xanthomatosis and effect induced by chenodeoxycholic acid.
Mondelli M; Rossi A; Scarpini C; Dotti MT; Federico A
Arch Neurol; 1992 May; 49(5):469-75. PubMed ID: 1316120
[TBL] [Abstract][Full Text] [Related]
14. Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study.
Llewelyn JG; Gilbey SG; Thomas PK; King RH; Muddle JR; Watkins PJ
Brain; 1991 Apr; 114 ( Pt 2)():867-92. PubMed ID: 2043955
[TBL] [Abstract][Full Text] [Related]
15. Chronic demyelinating peripheral neuropathy in cerebrotendinous xanthomatosis.
Argov Z; Soffer D; Eisenberg S; Zimmerman Y
Ann Neurol; 1986 Jul; 20(1):89-91. PubMed ID: 3017187
[TBL] [Abstract][Full Text] [Related]
16. Polyneuropathy with lipid deposits in Schwann cells and axonal degeneration in cerebrotendinous xanthomatosis.
Voiculescu V; Alexianu M; Popescu-Tismana G; Pastia M; Petrovici A; Dan A
J Neurol Sci; 1987 Dec; 82(1-3):89-99. PubMed ID: 2831311
[TBL] [Abstract][Full Text] [Related]
17. Polyneuropathy. Facts and fancies.
Buchthal F; Behse F
Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):373-83. PubMed ID: 220006
[TBL] [Abstract][Full Text] [Related]
18. Sensory action potentials and biopsy of the sural nerve in the neuropathy of nonmalignant IgMk plasma cell dyscrasia.
Galassi G; Nemni R
Eur Neurol; 1986; 25(1):1-9. PubMed ID: 3940860
[TBL] [Abstract][Full Text] [Related]
19. Somatosensory and motor evoked potentials in the assessment of cerebrotendinous xanthomatosis before and after treatment with chenodeoxycholic acid: a preliminary study.
Restuccia D; Di Lazzaro V; Servidei S; Colosimo C; Tonali P
J Neurol Sci; 1992 Oct; 112(1-2):139-46. PubMed ID: 1469424
[TBL] [Abstract][Full Text] [Related]
20. Hypothyroid polyneuropathy. Clinical, electrophysiological and nerve biopsy findings in two cases.
Pollard JD; McLeod JG; Honnibal TG; Verheijden MA
J Neurol Sci; 1982 Mar; 53(3):461-71. PubMed ID: 7069443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
